Author:
Maserumule Charlotte,Passemar Charlotte,Oh Olivia S H,Hegyi Kriztina,Brown Karen,Weimann Aaron,Dinan Adam,Davila Sonia,Klapholz Catherine,Bryant Josephine,Verma Deepshikha,Gadwa Jacob,Krishnananthasivam Shivankari,Vongtongsalee Kridakorn,Kendall Edward,Trelles Andres,Hibberd Martin L,Prados-Rosales Rafael,Andi Kaliappan,Kumar S Siva,Ordway Diane,MacAry Paul A,Floto R. Andres
Abstract
AbstractGenetic determinants of susceptibility to Mycobacterium tuberculosis (Mtb) are poorly understood but could provide insights into critical pathways involved in infection, informing host-directed therapies and enabling risk stratification at individual and population levels. Through a genome-wide forward genetic screen, we identify the Toll-like Receptor 8 (TLR8), as a key regulator of intracellular killing of Mtb. Pharmacological TLR8 activation enhances killing of phylogenetically diverse clinical isolates of drug-susceptible and multidrug-resistant Mtb by macrophages and during in vivo infection in mice. TLR8 is activated by phagosomal mycobacterial RNA released by extracellular membrane vesicles, and enhances xenophagy-dependent Mtb killing. We find that the TLR8 variant, M1V, common in far eastern populations, enhances intracellular killing of Mtb through preferential signal-dependent trafficking to phagosomes. TLR8 signalling may therefore both regulate susceptibility to tuberculosis and provide novel drug targets.Single sentence summaryRNA released from Mycobacterium tuberculosis in the macrophage phagosome is sensed by the pattern recognition receptor TLR8 controlling host susceptibility to tuberculosis and revealing a druggable pathway for host-directed therapy.
Publisher
Cold Spring Harbor Laboratory
Reference77 articles.
1. Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives
2. WHO 2021 report [Internet]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports
3. Dheda K , Gumbo T , Maartens G , Dooley KE , McNerney R , Murray M , et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017 Mar 15;S2213-2600(17)30079-6.
4. The within-host evolution of antimicrobial resistance in Mycobacterium tuberculosis;FEMS Microbiol Rev,2021
5. Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches;Trends Pharmacol Sci,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献